Skip to content

Clinical evaiuation of siddha drug Mega rajanga kirutham in the treatment of Leucorrhoea (vellai noi)

Clinical evaluation of Mega rajanga kirutham in the treatment of vellai noi(Leucorrhoea) - Mega rajanga kirutham

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008025
Enrollment
40
Registered
2017-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- VELLAI NOI(LEUCORRHOEA)

Interventions

Intervention1: MEGA RAJANGA KIRUTHAM(INTERNAL): 4 ml of Megarajanga kirutham administered orally twice a day for a period of 9 days twice a month. Control Intervention1: NIL: NIL Control Intervention2

Sponsors

Ayothidoss pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Married female, • Patient having the symptoms of whitish or yellowish discharge per vagina, • Pruritis vulva, vulval irritation, dysuria, abdominal pain, low backache • Patient who is willing to cooperate for vaginal swab examination & who undergo routine blood investigation. • Positive Wet test for Trichomonas vaginalis • Patient who is willing to participate in trial and signing in consent form

Exclusion criteria

Exclusion criteria: • Cases not confirmed by Wet test for Tr.vaginalis. • H/O Diabetes mellitus • H/O Bacterialvaginosis/Vulvovaginal candidiasis • H/O Sexually transmitted disease (syphilis, HIV, gonorrhoea) • H/O Non-specific leucorrhea • Pregnancy and lactation • H/OMalignancy

Design outcomes

Primary

MeasureTime frame
1) It is assessed by the vaginal smear when wet test becomes negative for Trichomonas vaginalis after treatment, 2) reduction of clinical symptoms such as white or yellowish discolouration per vagina, lower abdominal pain, low back pain, pruritus vulva, foul smell,dysuria and dispareunia.Timepoint: 27 days.

Secondary

MeasureTime frame
1)Socio economic status 2) Age related to the disease will be assessed.Timepoint: 27 days

Countries

India

Contacts

Public ContactDr H VETHA MERLIN KUMARI

National institute of siddha

periasamypandian22@gmail.com9884878469

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026